Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GALLBLADDER DISEASE 4
|
1 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.700 | 0 | ||||||||
Bile duct carcinoma
|
10 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Biliary Tract Cancer
|
11 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2011 | 2011 | |||||
Massive Osteolyses
|
11 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2010 | 2019 | |||||
Cholesterol gallstones
|
12 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||
Insulin resistance syndrome
|
15 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Low phospholipid-associated cholelithiasis
|
29 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Biliary calculi
|
31 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.700 | 1.000 | 4 | 2007 | 2019 | |||||
Familial hypercholesterolemia - heterozygous
|
34 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Gerstmann-Straussler-Scheinker Disease
|
39 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2010 | 2019 | |||||
Cholangiocarcinoma
|
43 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Cholecystolithiasis
|
62 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.800 | 1.000 | 11 | 2007 | 2018 | |||||
Gallbladder Carcinoma
|
75 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Malignant neoplasm of gallbladder
|
81 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Cholelithiasis
|
90 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.800 | 1.000 | 17 | 2007 | 2018 | |||||
Hypercholesterolemia
|
123 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.020 | 1.000 | 2 | 2004 | 2008 | |||||
Diabetic Nephropathy
|
238 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Coronary Arteriosclerosis
|
440 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Metabolic Syndrome X
|
591 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
C-reactive protein measurement
|
624 | 0.653 | 0.440 | 2 | 43839108 | missense variant | G/A;C | snv | 6.4E-06; 6.7E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 |